China Pharma Holdings Cash on Hand 2010-2023 | CPHI
China Pharma Holdings cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
China Pharma Holdings Annual Cash on Hand
(Millions of US $) |
| 2023 |
$1 |
| 2022 |
$2 |
| 2021 |
$5 |
| 2020 |
$1 |
| 2019 |
$1 |
| 2018 |
$2 |
| 2017 |
$3 |
| 2016 |
$4 |
| 2015 |
$6 |
| 2014 |
$6 |
| 2013 |
$6 |
| 2012 |
$4 |
| 2011 |
$4 |
| 2010 |
$4 |
| 2009 |
$4 |
China Pharma Holdings Quarterly Cash on Hand
(Millions of US $) |
| 2023-12-31 |
$1 |
| 2023-09-30 |
$1 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$1 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$2 |
| 2022-03-31 |
$4 |
| 2021-12-31 |
$5 |
| 2021-09-30 |
$0 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$1 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$2 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
$1 |
| 2019-09-30 |
$1 |
| 2019-06-30 |
$2 |
| 2019-03-31 |
$2 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$4 |
| 2018-03-31 |
$4 |
| 2017-12-31 |
$3 |
| 2017-09-30 |
$3 |
| 2017-06-30 |
$4 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$5 |
| 2016-06-30 |
$8 |
| 2016-03-31 |
$7 |
| 2015-12-31 |
$6 |
| 2015-09-30 |
$6 |
| 2015-06-30 |
$5 |
| 2015-03-31 |
$5 |
| 2014-12-31 |
$6 |
| 2014-09-30 |
$4 |
| 2014-06-30 |
$5 |
| 2014-03-31 |
$5 |
| 2013-12-31 |
$6 |
| 2013-09-30 |
$5 |
| 2013-06-30 |
$4 |
| 2013-03-31 |
$6 |
| 2012-12-31 |
$4 |
| 2012-09-30 |
$5 |
| 2012-06-30 |
$5 |
| 2012-03-31 |
$4 |
| 2011-12-31 |
$4 |
| 2011-09-30 |
$5 |
| 2011-06-30 |
$5 |
| 2011-03-31 |
$4 |
| 2010-12-31 |
$4 |
| 2010-09-30 |
$5 |
| 2010-06-30 |
$5 |
| 2010-03-31 |
$5 |
| 2009-12-31 |
$4 |
| 2009-09-30 |
$4 |
| 2009-06-30 |
$4 |
| 2009-03-31 |
$5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
